-
Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
(PAR-24-045)
National Institute on Deafness and Other Communication Disorders
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Advancing Translational Sciences
Office of Behavioral and Social Sciences Research
National Center for Advancing Translational Sciences
Application Receipt Date(s): November 19, 2024
-
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
(PAR-24-046)
National Institute on Deafness and Other Communication Disorders
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Advancing Translational Sciences
Office of Behavioral and Social Sciences Research
National Center for Advancing Translational Sciences
Application Receipt Date(s): November 19, 2024
-
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
(PAR-24-050)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): October 27, 2026
-
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
(PAR-24-051)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): January 7, 2028
-
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
(PAR-24-059)
National Institute on Minority Health and Health Disparities
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Nursing Research
Office of Research on Women's Health
Office of Disease Prevention
Application Receipt Date(s): January 7, 2027
-
Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional)
(RFA-AA-23-004)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): April 18, 2024
-
Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
(RFA-AG-24-040)
National Institute on Aging
Application Receipt Date(s): February 15, 2024
-
Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
(RFA-CA-24-006)
National Cancer Institute
Application Receipt Date(s): Not Applicable
-
Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed)
(RFA-DA-24-030)
National Institute on Drug Abuse
Application Receipt Date(s): February 8, 2024
-
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
(RFA-DA-25-012)
National Institute on Drug Abuse
Application Receipt Date(s): March 13, 2025
-
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
(RFA-DA-25-013)
National Institute on Drug Abuse
Application Receipt Date(s): March 13, 2025
-
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
(RFA-DK-25-003)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): October 23, 2024
-
HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed)
(RFA-HD-24-014)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
Application Receipt Date(s): December 19, 2023
-
HEAL Initiative: Limited Competition: Data Coordinating Center for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (U24 Clinical Trial Not Allowed)
(RFA-HD-24-015)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
Application Receipt Date(s): December 19, 2023
-
Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
(RFA-MD-24-001)
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): December 18, 2023
-
Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
(RFA-NS-24-013)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): February 20, 2024
-
Down Syndrome Cohort Research Sites (DS-CRS) for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U01 Clinical Trial Not Allowed)
(RFA-OD-24-003)
Office of the Director, NIH
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
Application Receipt Date(s): December 15, 2023
-
Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed)
(RFA-OD-24-004)
Office of the Director, NIH
National Institute on Aging
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
Application Receipt Date(s): December 15, 2023
-
Down Syndrome Clinical Cohort Coordinating Center (DS-4C) for the INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) (U54 Clinical Trial Not Allowed)
(RFA-OD-24-005)
Office of the Director, NIH
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
Application Receipt Date(s): January 26, 2024